Page last updated: 2024-12-05

2,5-diaminotoluene

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

2,5-diaminotoluene: RN given refers to parent cpd [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

2-methyl-1,4-phenylenediamine : A diamine in which the two amino groups are substituted into toluene at the 2- and 5-positions. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID7252
CHEBI ID53619
SCHEMBL ID34217
SCHEMBL ID10580512
MeSH IDM0050420

Synonyms (62)

Synonym
1,4-benzenediamine, 2-methyl-
toluene-2,5-diamine
2,5-diaminotoluene
2-methyl-p-phenylenediamine
p-toluylendiamine
hsdb 6251
4-amino-2-methylaniline
ccris 7693
para-toluenediamine
toluylene-2,5-diamine
einecs 202-442-1
2,5-toluenediamine
c.i. 76042
para-toluylenediamine
ci 76042
2-methyl-para-phenylenediamine
brn 0774521
p,m-tolylenediamine
2-methyl-1,4-benzenediamine
para-tolylenediamine
p-toluenediamine
benzenediamine, ar-methyl-
95-70-5
AC-11774
CHEBI:53619 ,
1-methyl-2,5-diaminobenzene
2-methyl-1,4-phenylenediamine
2,5-diamino-1-methylbenzene
2-methylbenzene-1,4-diamine
A845395
AKOS009158791
C19386
(4-amino-2-methyl-phenyl)-amine
24jo8z0rju ,
unii-24jo8z0rju
4-13-00-00246 (beilstein handbook reference)
FT-0609940
FT-0610504
EPITOPE ID:116061
2-hydroxy-n-(4-methyl-2-nitro-phenyl)-3-nitro-benzamide
SCHEMBL34217
2-methyl-1,4-benzenediamine [hsdb]
paratoluenediamine [mart.]
paratoluenediamine
1,4-diamino-2-methylbenzene
4-amino-3-methylaniline
2,5-diaminotoluene [iarc]
toluene-2,5-diamine [inci]
SCHEMBL10580512
OBCSAIDCZQSFQH-UHFFFAOYSA-N
D4628
DTXSID6029123 ,
mfcd00035779
GS-3190
2-methyl-benzene-1,4-diamine, aldrichcpr
p-toluylendiamin
2,5-diamino toluene
Q2521416
2 5-diaminotoluene sulphate (ptd)
SB40185
2-methyl-benzene-1,4-diamine
EN300-304949

Research Excerpts

Toxicity

ExcerptReferenceRelevance
" Previously, the Cosmetic Ingredient Review Expert Panel determined that all 3 ingredients were safe for use as hair dyes."( Final amended report of the safety assessment of toluene-2,5-diamine, toluene-2,5-diamine sulfate, and toluene-3,4-diamine as used in cosmetics.
Alan Andersen, F; Belsito, DV; Bergfeld, WF; Burnett, CL; Klaassen, CD; Marks, JG; Shank, RC; Slaga, TJ; Snyder, PW, 2010
)
0.36

Dosage Studied

ExcerptRelevanceReference
" Here we observed a clear shift of dose-response curves towards decreased genotoxicity of the parent aromatic amines in the NAT-proficient cells."( N-acetylation of three aromatic amine hair dye precursor molecules eliminates their genotoxic potential.
Pfuhler, S; Zeller, A, 2014
)
0.4
" The optimal dosage of PS in the reaction system was determined by efficiency indicator (I) coupling in the consumption of PS and decay half-life of TDA."( Degradation of toluene-2,4-diamine by persulphate: kinetics, intermediates and degradation pathway.
An, D; Jiang, YH; Li, MX; Xi, BD; Yang, Y; Zhang, JB,
)
0.13
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Roles (1)

RoleDescription
allergenA chemical compound, or part thereof, which causes the onset of an allergic reaction by interacting with any of the molecular pathways involved in an allergy.
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Drug Classes (1)

ClassDescription
diamineAny polyamine that contains two amino groups.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Research

Studies (38)

TimeframeStudies, This Drug (%)All Drugs %
pre-19904 (10.53)18.7374
1990's3 (7.89)18.2507
2000's9 (23.68)29.6817
2010's20 (52.63)24.3611
2020's2 (5.26)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 32.51

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index32.51 (24.57)
Research Supply Index3.81 (2.92)
Research Growth Index4.91 (4.65)
Search Engine Demand Index37.64 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (32.51)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials2 (4.76%)5.53%
Reviews1 (2.38%)6.00%
Case Studies5 (11.90%)4.05%
Observational0 (0.00%)0.25%
Other34 (80.95%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]